Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?

Although there are abundant data highlighting the safety and efficacy of direct oral anticoagulants, to date, recent guidelines have limited their use to stroke prevention in patients with non-valvular AF, as well as in the prevention and treatment of venous thromboembolism and pulmonary embolism. E...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahmoud Abdelnabi, Abdallah Almaghraby, Yehia Saleh
Format: Article
Language:English
Published: Radcliffe Medical Media 2020-02-01
Series:European Cardiology Review
Online Access:https://www.ecrjournal.com/articleindex/ecr.2019.1.3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850256510776508416
author Mahmoud Abdelnabi
Abdallah Almaghraby
Yehia Saleh
author_facet Mahmoud Abdelnabi
Abdallah Almaghraby
Yehia Saleh
author_sort Mahmoud Abdelnabi
collection DOAJ
description Although there are abundant data highlighting the safety and efficacy of direct oral anticoagulants, to date, recent guidelines have limited their use to stroke prevention in patients with non-valvular AF, as well as in the prevention and treatment of venous thromboembolism and pulmonary embolism. Encouraging data about the off-label use of direct oral anticoagulants have been shown in several other indications, such as intracardiac thrombi, left ventricular thrombi and left atrial appendage, but a large sector of patients are still not addressed, such as valvular and prosthetic patients.
format Article
id doaj-art-3f7a0c0fc0ee4d7b98debbb323263092
institution OA Journals
issn 1758-3756
1758-3764
language English
publishDate 2020-02-01
publisher Radcliffe Medical Media
record_format Article
series European Cardiology Review
spelling doaj-art-3f7a0c0fc0ee4d7b98debbb3232630922025-08-20T01:56:38ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642020-02-011510.15420/ecr.2019.1.3Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?Mahmoud Abdelnabi0Abdallah Almaghraby1Yehia Saleh2Cardiology and Angiology Unit, Department of Clinical and Experimental Internal Medicine, Medical Research Institute, University of Alexandria, EgyptDepartment of Cardiology, Faculty of Medicine, University of Alexandria, EgyptDepartment of Cardiology, Faculty of Medicine, University of Alexandria, Egypt; Michigan State University, East Lansing, MI, USAlthough there are abundant data highlighting the safety and efficacy of direct oral anticoagulants, to date, recent guidelines have limited their use to stroke prevention in patients with non-valvular AF, as well as in the prevention and treatment of venous thromboembolism and pulmonary embolism. Encouraging data about the off-label use of direct oral anticoagulants have been shown in several other indications, such as intracardiac thrombi, left ventricular thrombi and left atrial appendage, but a large sector of patients are still not addressed, such as valvular and prosthetic patients.https://www.ecrjournal.com/articleindex/ecr.2019.1.3
spellingShingle Mahmoud Abdelnabi
Abdallah Almaghraby
Yehia Saleh
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
European Cardiology Review
title Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
title_full Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
title_fullStr Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
title_full_unstemmed Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
title_short Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
title_sort will direct oral anticoagulants have a chance in prosthetic valves
url https://www.ecrjournal.com/articleindex/ecr.2019.1.3
work_keys_str_mv AT mahmoudabdelnabi willdirectoralanticoagulantshaveachanceinprostheticvalves
AT abdallahalmaghraby willdirectoralanticoagulantshaveachanceinprostheticvalves
AT yehiasaleh willdirectoralanticoagulantshaveachanceinprostheticvalves